Core targets of bisphenol A in cervical cancer revealed by network toxicology and molecular docking
Yi Li1, Wanjun Zhang1, Lin Tang1
1Department of Gynaecology and Obstetrics, Ya'an People's Hospital, Ya'an, Sichuan Province, People's Republic of China.
Abstract:
This study aimed to investigate the molecular mechanisms underlying BPA(Bisphenol A)-induced cervical cancer, to identify core targets and signaling pathways, and to provide a theoretical basis for disease prevention and therapeutic intervention. The chemical structure of BPA was obtained from PubChem(Public Chemical Database), and its toxicity profile was evaluated using ProTox-3.0. Potential BPA-associated targets were predicted using multiple databases and subsequently standardized. Differentially expressed genes (DEGs) in cervical cancer were identified from Gene Expression Omnibus datasets using the R programming language and integrated with Weighted Gene Co-expression Network Analysis (WGCNA) to determine key module genes. The cervical cancer-related target set was then established. Common targets between BPA and cervical cancer were identified using Venn diagram analysis, and a protein-protein interaction (PPI) network was constructed to screen for core targets. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analyses were performed to explore biological functions and pathways. Target gene expression was validated across multiple datasets, and molecular docking analysis was conducted using Cavity-Based Dock 2 (CB-Dock2). BPA exhibits endocrine toxicity and matrix metalloproteinase-mediated tissue damage, with 3 core targets identified across databases. In cervical cancer, 803 up-regulated and 1092 down-regulated DEGs were screened (|log2FC| ≥1, adjusted P <.05). WGCNA identified the turquoise module (normal group R = 0.98, P = 5 × 10-12; cancer group r = -0.98, P = 5 × 10-12), overlapping with 1110 DEGs. Nineteen common targets of BPA and cervical cancer were enriched in gene expression negative regulation and cancer pathways (hypergeometric test, false discovery rate (FDR) <0.05). PPI analysis confirmed Estrogen Receptor 1 (ESR1) and (Poly [ADP-ribose] Polymerase 1 (PARP1) as core targets: ESR1 was down-regulated (GSE122697: log2FC = -2.8, P <.0001; The Cancer Genome Atlas (TCGA): log2FC = -2.6, P <.0001), PARP1 up-regulated (GSE122697: log2FC = 3.1, P <.0001; TCGA: log2FC = 2.9, P = .0012). Both showed progressive expression changes with lesion advancement (GSE63514: ESR1 log2FC = -4.2, PARP1 log2FC = 4.5, P <.0001). Molecular docking revealed stable binding of BPA to ESR1 (-8.3 kcal/mol) and PARP1 (-8.5 kcal/mol, root-mean-square deviation [RMSD] <2.0 A). BPA may promote cervical carcinogenesis by interacting with ESR1 and PARP1 to regulate key cancer-related pathways. These targets may serve as potential biomarkers and therapeutic intervention points. Further experimental validation is required to confirm these findings.
Insights
Bisphenol A (BPA) may promote cervical cancer by interacting with Estrogen Receptor 1 (ESR1) and Poly [ADP-ribose] Polymerase 1 (PARP1). These key targets offer potential for novel biomarkers and therapeutic strategies in cervical cancer prevention and treatment.
Area of Science:
- Environmental Health
- Oncology
- Molecular Biology
Background:
- Bisphenol A (BPA) is an endocrine-disrupting chemical with known toxicity.
- Cervical cancer remains a significant global health concern.
- Understanding the molecular links between environmental exposures like BPA and cervical carcinogenesis is crucial for prevention and treatment.
Purpose of the Study:
- To elucidate the molecular mechanisms of BPA-induced cervical cancer.
- To identify core molecular targets and signaling pathways involved in this process.
- To provide a theoretical foundation for developing preventive and therapeutic strategies against BPA-associated cervical cancer.
Main Methods:
- Utilized bioinformatics tools and databases to predict BPA targets and analyze cervical cancer gene expression data (GEO, TCGA).
- Integrated Weighted Gene Co-expression Network Analysis (WGCNA) and protein-protein interaction (PPI) network analysis to identify key genes.
- Performed Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses.
- Validated target gene expression and conducted molecular docking simulations to assess BPA binding affinity.
Main Results:
- Identified 3 core BPA-associated targets and screened 803 up-regulated and 1092 down-regulated differentially expressed genes (DEGs) in cervical cancer.
- Estrogen Receptor 1 (ESR1) and Poly [ADP-ribose] Polymerase 1 (PARP1) were confirmed as core targets, showing significant differential expression and altered trends with disease progression.
- Molecular docking revealed stable binding of BPA to both ESR1 and PARP1, suggesting a direct interaction mechanism.
Conclusions:
- BPA may contribute to cervical carcinogenesis by interacting with ESR1 and PARP1, influencing key cancer-related pathways.
- ESR1 and PARP1 represent potential therapeutic targets and biomarkers for cervical cancer.
- Further experimental studies are warranted to validate these computational findings and their clinical implications.
More Related Videos
07:08Long-term Behavioral and Reproductive Consequences of Embryonic Exposure to Low-dose Toxicants
Published on: March 6, 2018
05:47In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
Published on: August 28, 2019
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancers Originate from Somatic Mutations in a Single Cell
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
